Novo Nordisk CEO: “We can’t solve the problem of expensive medicine alone”
While both Danes and the Danish government seem pleased with Novo Nordisk and the company’s enormous earnings, the large pharmaceutical company is not so popular in the US.Slimming drugs Wegovy and Ozempic are popular there too, but Novo’s prices are not. Hence, CEO Lars Fruergaard Jørgensen was summoned in front of US senators in Washington […]
Full version of this article is only available to subscribers.
Already a subscriber, sign in here:
Gain unlimited access to all of The Copenhagen Post
Our independent reporting can only be published with support from our readers.
Monthly subscription
119
DKK/month.
(Billed once a month)
Give us a try
6 month subscription
99
DKK/month.
(Billed twice a year)
Yearly subscription
79
DKK/month.
(Billed once a year)
The post Novo Nordisk CEO: “We can’t solve the problem of expensive medicine alone” appeared first on The Copenhagen Post.